WHO Nigeria rep assures of effective Covid-19 vaccines

Patent waiver seen stalling vaccine production in Nigeria

COVAX has secured enough vaccines to achieve 45 percent of coverage across countries by the middle of this year

The Nigeria Representative of the World Health Organization (WHO) said the agency has reduced the fear expressed in certain quarters about the efficacy and effects of the expected COVID-19 vaccines in the country. Maxwell Odika, a pharmacist, on behalf of the WHO Enugu State coordinator, at a one

```

Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```